Effect of rosemarinus officinalis l. on mmp-9, mcp-1 levels, and cell migration in RAW 264.7 and smooth muscle cells

Journal of Medicinal Food

Volumn 15, Issue 10, 2012, Pages 879-886

  Chae, In Gyeong ^a   Yu, Mi Hee ^a   Im, Nam Kyung ^a   Jung, Young Tae ^a   Lee, Jinho ^a   Chun, Kyung Soo ^a   Lee, In Seon ^a  

^a Keimyung University   (South Korea)

Author keywords

matrix metalloproteinase 9 (MMP 9); migration; monocyte chemoattractant protein 1 (MCP 1); RAW 264.7 macrophages; Rosemarinus officinalis L.; rosemary; vascular smooth muscle cell

Indexed keywords

CARNOSIC ACID; CARNOSOL; GELATINASE B; HEXANE; METHANOL; MONOCYTE CHEMOTACTIC PROTEIN 1; ROSMARINUS OFFICINALIS EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROSEMARY; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CHEMOKINE CCL2; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DITERPENES, ABIETANE; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLANT EXTRACTS; ROSMARINUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867300652     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2162     Document Type: Article

References (36)

1. Mestas J, Ley K: Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med 2008;18:228-232.
2. Kaplan MJ: Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheum 2009;5:208-217.
3. Jara LJ, Medina G, Vera-Lastra O, Amigo MC: Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun Rev 2006;5:195-201.
4. Sullivan GW, Sarembock IJ, Linden J: The role of inflammation in vascular diseases. J Leukocyte Biol 2000;67:591-602.
5. Raines EW, Ferri N: Thematic review series: the immune system and atherogenesis, cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005;46:1081-1092.
6. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
7. Nagaoka I, Hirota S: Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs. Inflamm Res 2000;49:55-62.
8. Maeda K, Kuzuya M, Cheng XW, Asai T, Kanda S, Tamayamori N, Sasaki T, Shibata T, Iguchi A: Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis 2003;166:23-30.
9. Jones CB, Sane DC, Herrington DM: Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003;59:812-823.
10. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002;91:852-859.
11. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
12. Mehdi JH, Rudabeh SM, Hassan S: Analysis of Iranian rosemary essential oil: application of gas chromatography-mass spectrometry combined with chemometrics. J Chromatogr A 2011; 1218:2569-2576.
13. Richheimer SL, Bernart MW, King GA, Kent MC, Bailey DT: Antioxidant activity of lipid soluble phenolic diterpenes from rosemary. J Am Oil Chem Soc 1996;73:507-514.
14. Singletary K, MacDonald C, Wallig M: Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 1996;104:43-48.
15. Aruoma OI, Spencer JP, Rossi R, Aeschbach R, Khan A, Mahmood N, Munoz A, Murcia A, Butler J, Halliwell B: An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provençal herbs. Food Chem Toxicol 1996; 34:449-456.
16. Altinier G, Sosa S, Aquino RP, Mencherini T, Della Loggia R, Tubaro A: Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem 2007; 55:1718-1723.
17. Okamura N, Fujimoto Y, Kuwabara S, Yagi A: High performance liquid chromatographic determination of carnosic acid and carnosol in Rosmarinus officinalis and Salvia officinalis. J Chromatogr A 1993;679:381-386.
18. Senorans FJ, Ibanez E, Cavero S, Tabera J, Reglero G: Liquid chromatographic-mass spectrometric analysis of supercritical-fluid extracts of rosemary plants. J Chromatogr A 2000;870:491-499.
19. Ramirez P, Garcia-Risco MR, Santoyo S, Senorans FJ, Ibanez E, Reglero G: Isolation of functional ingredients from rosemary by preparative-supercritical fluid chromatography (Prep-SFC). J Pharm Biomed Anal 2006;41:1606-1613.
20. Almela L, Sanchez-Munoz B, Fernandez-Lopez JA, Roca MJ, Rabe V: Liquid chromatograpic-mass spectrometric analysis of phenolics and free radical scavenging activity of rosemary extract from different raw material. J Chromatogr A 2006;1120:221-229.
21. Huang MT, Ho CT, Wang ZY, FerraroT, Lou YR, Stauber K, Ma W, Georgiadis C, Laskin JD, Conney AH: Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994;54:701-708.
22. Luis JC, Martin Perez R, Valdes Gonzalez F: UV-B radiation effects on foliar concentrations of rosmarinic and carnosic acids in rosemary plants. Food Chem 2007;101:1211-1215.
23. Baskan S, Oztekin N, Erim B: Determination of carnosic acid and rosmarinic acid in sage by capillary electrophoresis. Food Chem 2007;101:1748-1752.
24. Sotelo-Félix JI, Martinez-Fong D, Muriel de la Torre P: Protective effect of carnosol on CCl(4)-induced acute liver damage in rats. Eur J Gastroenterol Hepatol 2002;14:1001-1006.
25. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ: Matrix metalloproteinases. Br J Surg 1997;84:160-166.
26. McMillan JI, Weeks R, West JW, Busten S, Rice GC, Lovett DH: Pharmacological inhibition of gelatinase B induction and tumor cell invasion. Int J Cancer 1996;67:523-531.
27. Yoshimura T, Takeya M, Takahashi K, Kuratsu JI, Leonard EJ: Production and characterization of mouse monoclonal antibodies against human monocyte chemoattractant protein-1. J Immunol 1991;147:2229-2233.
28. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptordeficient mice. Mol Cell 1998;2:275-281.
29. Chambers AF, Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-1270.
30. Nabeshima K, Inoue T, Shimao Y, Sameshima T: Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 2002;52:255-264.
31. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic, Semin. Cancer Biol 1996;7:147-154.
32. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert Ra, Aoats S, Hawkins SM, Clowes AW: Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999;85:1179-1185.
33. Braunwald E: Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
34. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H: Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001;276:29596-29602.
35. Aruoma OI, Haliwell B, Aeschbach R, Loligers J: Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica 1992;22:257-268.
36. Bai N, He K, Roller M, Lai CS, Shao X, Pan MH, Ho CT: Flavonoids and phenolic compounds from Rosemarinus officinalis. J Agric Food Chem 2010;58:5363-5367.